L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Psychiatry

• Publication date

  2012-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/appi.ajp.2012.11071114PMID 23212058
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

  2012cited by this paper
• Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials.

  2011cited by this paper
• S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.

  2010cited by this paper
• Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials.

  2009cited by this paper
• An examination of the efficiency of the sequential parallel design in psychiatric clinical trials

  2007cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).

  2005cited by this paper
• The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.

  2005cited by this paper
• The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation

  2004cited by this paper
• Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.

  2004cited by this paper
• Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.

  2004cited by this paper
• S-Adenosyl-L-Methionine (SAMe) as an Adjunct for Resistant Major Depressive Disorder: An Open Trial Following Partial or Nonresponse to Selective Serotonin Reuptake Inhibitors or Venlafaxine

  2004cited by this paper
• The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

  2003cited by this paper
• Prediction of Treatment Response in Geriatric Depression From Baseline Folate Level: Interaction With an SSRI or a Tricyclic Antidepressant

  2003cited by this paper
• Folinic Acid (Leucovorin) as an Adjunctive Treatment for SSRI-Refractory Depression

  2002cited by this paper
• Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial.

  2000cited by this paper
• Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.

  2000cited by this paper
• Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.

  1999cited by this paper
• Folate, vitamin B12, and homocysteine in major depressive disorder.

  1997cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Change in folate status with antidepressant treatment.

  1994cited by this paper
• 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT.

  1994cited by this paper
• Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: Results of a double-blind multicenter study

  1993cited by this paper
• An open trial of methyltetrahydrofolate in elderly depressed patients.

  1993cited by this paper
• Enhancement of recovery from psychiatric illness by methylfolate

  1992cited by this paper
• Folate deficiency, biopterin and monoamine metabolism in depression

  1992cited by this paper
• Enhancement of recovery from psychiatric illness by methylfolate.

  1990cited by this paper
• Serum and red blood cell folate in depression

  1989cited by this paper
• Folic acid enhances lithium prophylaxis.

  1986cited by this paper
• Antiepileptic Therapy, Folate Deficiency, and Psychiatric Morbidity: A General Practice Survey

  1985cited by this paper
• Folic acid deficiency and depression.

  1980cited by this paper
• The neuropsychiatry of megaloblastic anaemia.

  1980cited by this paper
• Folate deficiency in depressive illness.

  1970cited by this paper
• Serum folate values in 423 psychiatric patients.

  1967cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Blood Concentrations of Folic Acid and Homocysteine Are Associated with Treatment-Resistant Depression Among Female Depressed Patients

  2026cites this paper
• The Role of Folate Receptor α Autoantibodies in Folate Deficiency, Disease Severity, and Treatment Response in Adolescents with Major Depressive Disorder.

  2025cites this paper
• S-adenosyl-l-methionine modulates hippocampal DNA methylation, exerting fast and long-lasting anti-stress effects independent of alterations in TrkB-mTOR expression

  2025cites this paper
• Unraveling Gender Differences in Obsessive-Compulsive Disorder: A Focus on Key Micronutrients

  2025cites this paper
• Understanding the research landscape of over-the-counter herbal products, dietary supplements, and medications evaluated for depressive symptoms in adults: a scoping review

  2025cites this paper
• Dietary food folate and synthetic folic acid co-exposure patterns with elevated depressive symptoms: Findings from NHANES 2005-2018.

  2025cites this paper
• Biomarkers in the Diagnosis and Prediction of Medication Response in Depression and the Role of Nutraceuticals

  2024cites this paper
• A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants

  2024cites this paper
• Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder.

  2024cites this paper
• Discovering the Potential Value of Coenzyme Q10 as an Adjuvant Treatment in Patients With Depression

  2024cites this paper
• Natural Substances in the Adjuvant Therapy of Depression

  2024cites this paper
• Rethinking the efficacy of natural and synthetic folic acid on human health and looking into a better alternative

  2024cites this paper
• Targeting Divergent Pathways in the Nutritional Management of Depression

  2024cites this paper
• Pharmacogenetic Testing in Treatment-resistant Panic Disorder: a Preliminary Analysis

  2024cites this paper
• Folate and Its Significance in Depressive Disorders and Suicidality: A Comprehensive Narrative Review

  2023cites this paper
• The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents

  2023cites this paper
• Effect of folic acid on the sexual function of postmenopausal women: a triple-blind randomized controlled trial.

  2023cites this paper
• How should we design future mechanistic and/or efficacy clinical trials?

  2023cites this paper
• Distribution of pharmacogene allele and phenotype frequencies in Brazilian psychiatric patients.

  2023cites this paper
• Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign.

  2023cites this paper
• Strategies to Implement the Use of Supplements versus Psychotropics in a Pediatric and Adolescent Population: A Quality Improvement Project

  2023influential citation
• Folic acid supplementation during pregnancy and postpartum depressive symptoms

  2023cites this paper
• A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult

  2023cites this paper
• Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials

  2022cites this paper
• L-Methylfolate in Antidepressant Non-responders: The Impact of Body Weight and Inflammation

  2022cites this paper
• Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment refractory depression and suicidal behavior

  2022cites this paper
• Neuronutrients And Central Nervous System: A Systematic Review.

  2022cites this paper
• A retrospective examination of adjunctive L-methylfolate in children and adolescents with unipolar depression.

  2022cites this paper
• BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions

  2022cites this paper
• 5-Methyltetrahydrofolate Alleviates Memory Impairment in a Rat Model of Alzheimer’s Disease Induced by D-Galactose and Aluminum Chloride

  2022cites this paper
• Effect of folic acid supplementation on mental health in the antenatal and postnatal period

  2022cites this paper
• Women Taking a Folic Acid Supplement in Countries with Mandatory Food Fortification Programs May Be Exceeding the Upper Tolerable Limit of Folic Acid: A Systematic Review

  2022cites this paper
• Prevalence of depressive symptoms and correlated factors among pregnant women during their second and third trimesters in northwest rural China: a cross-sectional study

  2022cites this paper
• Behavioral and neurochemical effects of folic acid in a mouse model of depression induced by TNF-α.

  2021cites this paper
• Modeling heritability of temperamental differences, stress reactivity, and risk for anxiety and depression: Relevance to research domain criteria (RDoC)

  2021cites this paper
• Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence

  2021influential citation
• Treatment-Resistant Depression Revisited: A Glimmer of Hope

  2021cites this paper
• Treatment resistant depression

  2021cites this paper
• Biology of Perseverative Negative Thinking: The Role of Timing and Folate Intake

  2021cites this paper
• Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders

  2021cites this paper
• MTHFR GENE MUTATION AND ITS REPERCUSSION IN THE GENESIS AND TREATMENT OF DEPRESSION: CASE REPORT

  2021cites this paper
• Effect of pharmacogenomic testing on pharmacotherapy decision making in patients with symptoms of depression in an interprofessional primary care clinic.

  2021cites this paper
• Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications

  2021cites this paper
• Key considerations in the pharmacological management of treatment-resistant depression

  2021cites this paper
• Current Research on Complementary and Alternative Medicine (CAM) in the Treatment of Major Depressive Disorder: An Evidence-Based Review.

  2021cites this paper
• Targeted Metabolomics: The LC-MS/MS Based Quantification of the Metabolites Involved in the Methylation Biochemical Pathways

  2021cites this paper
• Improvement of cognitive performance by a nutraceutical formulation: Underlying mechanisms revealed by laboratory studies.

  2021cites this paper
• A Comparative Study of Aripiprazole, Olanzapine, and L-Methylfolate Augmentation in Treatment Resistant Obsessive-Compulsive Disorder

  2021cites this paper
• Clinical and Laboratory Correlates Of Depression among Kidney Disease Patients: A Cross-Sectional Study

  2021cites this paper
• Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects

  2021cites this paper
• Plasma homocysteine concentrations and depression: A twin study.

  2021cites this paper
• The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review.

  2021cites this paper
• Pharmacodynamic Gene Testing in Prader-Willi Syndrome

  2020cites this paper
• Vitamin B12 and Folic Acid in Depression and Anxiety: A Pilot Study

  2020cites this paper
• Pregnancy outcomes in women with epilepsy and MTHFR mutations supplemented with methylated folate and methylcobalamin (methylated B12)

  2020cites this paper
• The Role of Folate and MTHFR Polymorphisms in the Treatment of Depression.

  2020cites this paper
• Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry

  2020cites this paper
• L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study.

  2020cites this paper
• Leveraging CAM to treat depression and anxiety.

  2020cites this paper
• Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression

  2020cites this paper
• Can precision medicine advance psychiatry?

  2020cites this paper
• Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease

  2020cites this paper
• Predicting SSRI-Resistance: Clinical Features and tagSNPs Prediction Models Based on Support Vector Machine

  2020cites this paper
• Inadequate Response to Antidepressant Treatment in Major Depressive Disorder.

  2020cites this paper
• Tetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry.

  2020cites this paper
• Antidepressant efficacy and side effect burden: an updated guide for clinicians

  2020cites this paper
• Nutraceutical Augmentation Strategies for Depression: A Narrative Review

  2020cites this paper
• Adjunctive folate for major mental disorders: A systematic review.

  2020cites this paper
• Impact of the MTHFR C677T genetic variant on depression

  2020cites this paper
• Enrichment designs using placebo nonresponders

  2020cites this paper
• Broad spectrum micronutrient formulas for the treatment of symptoms of depression, stress, and/or anxiety: a systematic review

  2020cites this paper
• Diet, Stress and Mental Health

  2020cites this paper
• Update on the pharmacological treatment of resistant depression

  2019cites this paper
• Role of Inflammation in Depression and Treatment Implications.

  2019cites this paper
• Nutrition in Neurocognition and Mental Health

  2019cites this paper
• EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy

  2019cites this paper
• Authors’ reply

  2019cites this paper
• Current Role of Herbal and Natural Preparations.

  2019cites this paper
• Impact de l’alimentation sur les troubles dépressifs de l’adulte et leur prise en charge : synthèse de la littérature

  2019cites this paper
• L-Methylfolate Calcium Supplementation in Adolescents and Children: A Retrospective Analysis

  2019cites this paper
• Neurometabolic approach to treatment-resistant depression

  2019cites this paper
• Methylenetetrahydrofolate Reductase Screening in Treatment-Resistant Depression.

  2019cites this paper
• Role of DNA hypomethylation in lateral habenular nucleus in the development of depressive-like behavior in rats.

  2019cites this paper
• Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

  2019cites this paper
• L-methylfolate Augmentation to Antidepressants for Adolescents with Treatment-Resistant Depression: A Case Series

  2019influential citation
• The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B12, B6, and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis.

  2019cites this paper
• The Role of Brain Barriers in Maintaining Brain Vitamin Levels.

  2019cites this paper
• A commentary on: statistical inference problems in sequential parallel comparison designs

  2019cites this paper
• New Treatment Options for Depression: A Primer for Internists.

  2019cites this paper
• Novel Therapeutic Targets for Major Depressive Disorder

  2019cites this paper
• Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression

  2019cites this paper
• Optimized Treatment Strategy for Depressive Disorder.

  2019cites this paper
• Depressive Disorders: Mechanisms, Measurement and Management

  2019cites this paper
• Sequential parallel comparison design with two coprimary endpoints

  2019cites this paper
• The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Unipolar Nonpsychotic Depression.

  2019cites this paper
• A Prenatal Supplement with Methylfolate for the Treatment and Prevention of Depression in Women Trying to Conceive and during Pregnancy

  2019cites this paper
• Good, better, best: clinical scenarios for the use of L-methylfolate in patients with MDD

  2019influential citation
• Pharmacogenetics and Psychiatric Care: A Review and Commentary

  2018cites this paper
• Complementary and Alternative Medicine (CAM) as Treatments for Psychiatric Disorders: A Guide for Mental Health Professionals

  2018cites this paper
• Experimental Therapies for Treatment-Resistant Depression: "How do you decide when to go to an unproven or experimental therapy with patients that are treatment-resistant depression?"

  2018cites this paper